Articles
-
Aug 22, 2024 |
medium.com | Benjamin Li
Maybe a lake near you just got closed off to swimmers. Or perhaps you’ve observed never-before-seen, dense clumps of algae on the surface? You might be witnessing a harmful algal bloom (HAB). Before we get into how these blooms are detected and mitigated, let’s see the US National Institute of Environmental Health Sciences’ definition. HABs pose numerous threats to ecosystem and human health which are commonly evident in sudden, rapid mass deaths of aquatic organisms such as fish.
-
Aug 20, 2024 |
cancernetwork.com | Adam Brufsky |Xianchen Liu |Benjamin Li |Lynn McRoy |Doris Makari |Rachel M. Layman | +2 more
BackgroundCardiovascular diseases (CVDs) can impact breast cancer treatment selection and clinical outcomes. A CDK4/6 inhibitor combined with endocrine therapy (ET) is now the standard of care as a first-line treatment for patients with hormone receptor–positive (HR+)/HER2-negative (HER2–) metastatic breast cancer. However, the effectiveness data of CDK4/6 inhibitors in patients with metastatic breast cancer and CVD are limited.
-
Jul 25, 2024 |
cancernetwork.com | Heather Moore |Avirup Guha |Irene Arias |Stella Stergiopoulos |Benjamin Li |Michael G. Fradley | +3 more
BackgroundThe prevalence of preexisting cardiovascular (CV) comorbidities at diagnosis of hormone receptor-positive (HR+)/HER2-negative (HER2–) metastatic breast cancer (mBC) has not been well established. We aimed to describe the prevalence of preexisting CV comorbidities in patients with newly diagnosed HR+/HER2– mBC and to describe the first documented cancer treatment and concurrent medications with risk of QT interval (QTc) prolongation for patients with or without CV comorbidities.
-
Jun 30, 2024 |
medium.com | Benjamin Li
In 2022, large language models rapidly became a prominent aspect of everyone's lives with the release of OpenAI's ChatGPT (GPT-3.5 and GPT-4). Used everywhere as classroom aides, computer programming assistants, and for diagnosing medical conditions, large language models (LLMs) seem to have no limit to their potential applications. Meanwhile, recognizing and addressing risks associated with these algorithms is important for ethical and practical use in daily life.
-
Jun 30, 2024 |
medium.com | Benjamin Li
What are some barriers we need to traverse before achieving sweeping adoption of AI in healthcare? Three years ago, not many people outside industry and academia were thoroughly invested in artificial intelligence (AI), machine learning (ML), and deep learning (DL). That is, until the so-called "AI boom", spurred by OpenAI's release of ChatGPT (GPT-3.5) in the fall of 2022. All of a sudden, AI was making headlines and invading all aspects of daily life.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →